Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atherosclerosis

被引:26
作者
DeRijke, YB
Verwey, HF
Vogelezang, CJM
VanderVelde, EA
Princen, HMG
VanderLaarse, A
Bruschke, AVG
VanBerkel, TJC
机构
[1] LEIDEN UNIV,SYLVIUS LABS,LACDR,DIV BIOPHARMACEUT,2300 RA LEIDEN,NETHERLANDS
[2] LEIDEN UNIV HOSP,DEPT CARDIOL,2333 AA LEIDEN,NETHERLANDS
[3] LEIDEN UNIV,DEPT MED STAT,2300 RA LEIDEN,NETHERLANDS
[4] TNO,IVVO,GAUBIUS LAB,2300 AK LEIDEN,NETHERLANDS
关键词
coronary atherosclerosis; coronary artery bypass surgery; low-density lipoprotein; apolipoprotein B; lipid peroxidation;
D O I
10.1016/0009-8981(95)06163-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Oxidation of low-density lipoprotein (LDL) may play a causal role in atherosclerosis. In this study we analyzed whether the severity of progression of coronary atherosclerosis is related to the susceptibility of LDL to oxidative modification. On the basis of repeated coronary angiography, 28 coronary bypass patients were divided into two groups: group A, 12 patients with, and group B, 16 patients without progression of coronary atherosclerosis. The lag time, reflecting the resistance of LDL to oxidative modification, was significantly smaller in group A as compared with group B (81 +/- 10 and 93 +/- 15 min, respectively). Besides differences in cholesterol and apolipoprotein B concentrations, the difference in susceptibility of LDL to oxidation significantly contributes to the differences between the progression and the nonprogression group (P = 0.02). In the combined groups of patients, the lag phase of LDL for oxidation was positively correlated with LDL cholesterol ester to protein ratio (r = 0.53, P = 0.01). It is concluded that LDL samples obtained from coronary bypass patients differ with respect to their oxidizability depending on progression of atherosclerosis following coronary bypass surgery.
引用
收藏
页码:137 / 149
页数:13
相关论文
共 42 条
  • [1] ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK
    AUSTIN, MA
    KING, MC
    VRANIZAN, KM
    KRAUSS, RM
    [J]. CIRCULATION, 1990, 82 (02) : 495 - 506
  • [2] AVIRAM M, 1988, J BIOL CHEM, V263, P16842
  • [3] VITAMIN-E CONTENT AND LOW-DENSITY-LIPOPROTEIN OXIDIZABILITY INDUCED BY FREE-RADICALS
    BABIY, AV
    GEBICKI, JM
    SULLIVAN, DR
    [J]. ATHEROSCLEROSIS, 1990, 81 (03) : 175 - 182
  • [4] THE RELATION OF RISK-FACTORS TO THE DEVELOPMENT OF ATHEROSCLEROSIS IN SAPHENOUS-VEIN BYPASS GRAFTS AND THE PROGRESSION OF DISEASE IN THE NATIVE CIRCULATION - A STUDY 10 YEARS AFTER AORTOCORONARY BYPASS-SURGERY
    CAMPEAU, L
    ENJALBERT, M
    LESPERANCE, J
    BOURASSA, MG
    KWITEROVICH, P
    WACHOLDER, S
    SNIDERMAN, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) : 1329 - 1332
  • [5] LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE AND CORONARY-ARTERY DISEASE
    CAMPOS, H
    GENEST, JJ
    BLIJLEVENS, E
    MCNAMARA, JR
    JENNER, JL
    ORDOVAS, JM
    WILSON, PWF
    SCHAEFER, EJ
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (02): : 187 - 195
  • [7] PREDISPOSITION TO LDL OXIDATION IN PATIENTS WITH AND WITHOUT ANGIOGRAPHICALLY ESTABLISHED CORONARY-ARTERY DISEASE
    COMINACINI, L
    GARBIN, U
    PASTORINO, AM
    DAVOLI, A
    CAMPAGNOLA, M
    DESANTIS, A
    PASINI, C
    FACCINI, GB
    TREVISAN, MT
    BERTOZZO, L
    PASINI, F
    LOCASCIO, V
    [J]. ATHEROSCLEROSIS, 1993, 99 (01) : 63 - 70
  • [8] ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION OF THE DENSE LOW-DENSITY-LIPOPROTEIN SUBFRACTION IN HEALTHY-SUBJECTS
    DEGRAAF, J
    HAKLEMMERS, HLM
    HECTORS, MPC
    DEMACKER, PNM
    HENDRIKS, JCM
    STALENHOEF, AFH
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02): : 298 - 306
  • [9] IDENTIFICATION OF MULTIPLE DENSE LDL SUBFRACTIONS WITH ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION AMONG HYPERTRIGLYCERIDEMIC SUBJECTS - NORMALIZATION AFTER CLOFIBRATE TREATMENT
    DEGRAAF, J
    HENDRIKS, JCM
    DEMACKER, PNM
    STALENHOEF, AFH
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (05): : 712 - 719
  • [10] DIEBERROTHENEDER M, 1991, J LIPID RES, V32, P1325